Following the U.S. Food and Drug Administration’s recent approval of Parsabiv™ (etelcalcetide), an IV formulation equivalent to the oral calcimimetic Sensipar® (cinacalcet), dialysis providers like … [Read more...]
Intravenous Form of Sensipar® Has Been Approved by the FDA
Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
